Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-C chemokine receptor type 4 (CCR4), also known as CD194, is a G protein-coupled receptor primarily functioning as a cell-surface receptor for CC chemokines CCL17 (TARC) and CCL22 (MDC). It plays a key role in immune system development, inflammation, and cell migration, especially of Th2 cells and Tregs. CCR4 is implicated in several pathological conditions, including allergic diseases and cancer, particularly CTCL, and is a target for therapeutic intervention.
Monoclonal antibody targeting CCR4, leading to depletion of CCR4-expressing cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-C Chemokine Receptor Type 4 (CCR4).